Zavesca (Actelion Pharmaceuticals US, Inc.)
Welcome to the PulseAid listing for the Zavesca drug offered from Actelion Pharmaceuticals US, Inc.. This Glucosylceramide Synthase Inhibitor [EPC],Glucosylceramide Synthase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actelion Pharmaceuticals US, Inc. |
| NON-PROPRIETARY NAME: | miglustat |
| SUBSTANCE NAME: | MIGLUSTAT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Glucosylceramide Synthase Inhibitor [EPC],Glucosylceramide Synthase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2003-07-31 |
| END MARKETING DATE: | 0000-00-00 |
Zavesca HUMAN PRESCRIPTION DRUG Details:
| Item Description | Zavesca from Actelion Pharmaceuticals US, Inc. |
| LABELER NAME: | Actelion Pharmaceuticals US, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2003-07-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66215-201_fc629ed9-b52c-4dad-8a09-89e65b277ff7 |
| PRODUCT NDC: | 66215-201 |
| APPLICATION NUMBER: | NDA021348 |
Other MIGLUSTAT Pharmaceutical Manufacturers / Labelers:
